Live Breaking News & Updates on Institutional trading of vertex pharmaceuticals

Stay updated with breaking news from Institutional trading of vertex pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Insider Selling: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) CMO Sells 5,651 Shares of Stock

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) CMO Carmen Bozic sold 5,651 shares of Vertex Pharmaceuticals stock in a transaction dated Tuesday, October 3rd. The stock was sold at an average price of $345.28, for a total transaction of $1,951,177.28. Following the transaction, the chief marketing officer now directly owns 46,254 shares in the […] ....

Wellington , New-zealand-general , New-zealand , Zurich , Züsz , Switzerland , Canada , Carmen-bozic , Sanfordc-bernstein , Vertex-pharmaceuticals-incorporated , Institutional-trading-of-vertex-pharmaceuticals , News-ratings-for-vertex-pharmaceuticals-daily

Analysts Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Target Price at $367.04

Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have received an average rating of “Moderate Buy” from the eighteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average […] ....

Zurich , Züsz , Switzerland , Canada , Wellington , New-zealand-general , New-zealand , Brucei-sachs , Sangeetan-bhatia , Vertex-pharmaceuticals-incorporated , Vertex-pharmaceuticals-price-performance

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at StockNews.com

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Monday. Several other equities research analysts have also issued reports on the stock. Canaccord Genuity Group boosted their price target on shares […] ....

Kentucky , United-states , Brucei-sachs , Ourania-tatsis , Sanfordc-bernstein , Securities-exchange-commission , Marquette-asset-management , Vertex-pharmaceuticals-company-profile , Vertex-pharmaceuticals , Morgan-stanley , Independence-bank , Vertex-pharmaceuticals-stock-performance

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $352.00 at Morgan Stanley

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $352.00 at Morgan Stanley
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Kentucky , United-states , America , Bastiano-sanna , Brucei-sachs , Institutional-trading-of-vertex-pharmaceuticals , Yd-more-investments-ltd , Morgan-stanley , Vertex-pharmaceuticals-incorporated , Analyst-recommendations-for-vertex-pharmaceuticals , Marquette-asset-management , Steward-financial-group

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Reiterated by HC Wainwright

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They currently have a $380.00 price objective on the pharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 6.03% from the company’s current price. […] ....

Kristen-ambrose , Stifel-nicolaus , Stuarta-arbuckle , Institutional-trading-of-vertex-pharmaceuticals , Schechter-investment-advisors , Vertex-pharmaceuticals-incorporated , Venturi-wealth-management , Vertex-pharmaceuticals-stock , Comerica-bank , Analyst-recommendations-for-vertex-pharmaceuticals , Sequoia-financial-advisors , Securities-exchange-commission